| Title |
SEOM clinical guidelines in early-stage breast cancer 2015
|
|---|---|
| Published in |
Clinical and Translational Oncology, October 2015
|
| DOI | 10.1007/s12094-015-1427-3 |
| Pubmed ID | |
| Authors |
J. A. Garcia-Saenz, B. Bermejo, L. G. Estevez, A. G. Palomo, X. Gonzalez-Farre, M. Margeli, S. Pernas, S. Servitja, C. A. Rodriguez, E. Ciruelos |
| Abstract |
Breast cancer is a major public health problem. Despite remarkable advances in early diagnosis and treatment, one in three women may have metastases since diagnosis. Better understanding of prognostic and predictive factors allows us to select the most appropriate adjuvant therapy in each patient. In these guidelines, we summarize current evidence for the medical management of early-stage breast cancer. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Spain | 1 | 2% |
| Unknown | 56 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 21% |
| Student > Master | 10 | 17% |
| Other | 9 | 16% |
| Student > Bachelor | 7 | 12% |
| Student > Postgraduate | 4 | 7% |
| Other | 8 | 14% |
| Unknown | 8 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 52% |
| Agricultural and Biological Sciences | 6 | 10% |
| Nursing and Health Professions | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 3 | 5% |
| Economics, Econometrics and Finance | 2 | 3% |
| Other | 2 | 3% |
| Unknown | 11 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2015.
All research outputs
#17,776,263
of 22,831,537 outputs
Outputs from Clinical and Translational Oncology
#772
of 1,305 outputs
Outputs of similar age
#191,659
of 284,375 outputs
Outputs of similar age from Clinical and Translational Oncology
#14
of 30 outputs
Altmetric has tracked 22,831,537 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,305 research outputs from this source. They receive a mean Attention Score of 3.7. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,375 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.